Indeed, the TCGA database indicates that NINJ2 is over-expressed in ovarian serous cystadenocarcinoma and pancreatic adenocarcinoma, both of which are characterized by a high rate of p53 mutation [45,46,47]. The gene discussed is TP53; the disease is pancreatic adenocarcinoma.